United States · FDA National Drug Code directory
Migraine Ease
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68703-375_2ab0f647-0254-0e1c-e063-6294a90a74b2
- Product NDC
- 68703-375
- Form
- TABLET
- Composition / generic term
- Belladonna, Bryonia, Cimicifuga, Gelsemium, Glonoinum, Ignatia, Iris vers, Nux vom, Sanguinaria, Sepia, Spigelia anth
- Labeler
- Silver Star Brands
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20211220
- Source listing expiry
- 20261231
Source-listed ingredients
- ATROPA BELLADONNA — 12 [hp_C]/1801
- SPIGELIA ANTHELMIA — 12 [hp_C]/1801
- SANGUINARIA CANADENSIS ROOT — 12 [hp_C]/1801
- IRIS VERSICOLOR ROOT — 12 [hp_C]/1801
- STRYCHNOS NUX-VOMICA SEED — 12 [hp_C]/1801
- BRYONIA ALBA ROOT — 12 [hp_C]/1801
- NITROGLYCERIN — 12 [hp_C]/1801
- SEPIA OFFICINALIS JUICE — 12 [hp_C]/1801
- ACTAEA CIMICIFUGA ROOT — 12 [hp_C]/1801
- GELSEMIUM SEMPERVIRENS ROOT — 12 [hp_C]/1801
- STRYCHNOS IGNATII SEED — 12 [hp_C]/1801
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET in 1 BOTTLE, GLASS (68703-375-80) · 68703-375-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →